Global Contract Pharmaceutical Manufacturing Consumption Market Report 2021

Publisher Name :
Date: 14-Sep-2016
No. of pages: 112
Inquire Before Buying

This report studies sales (consumption) of Contract Pharmaceutical Manufacturing in Global market, especially in North America, China, Europe, Japan, Southeast Asia and India, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

Catalent

DPx

Lonza

Piramal Healthcare

Aenova

Jubilant

Famar

Boehringer Ingelheim

Fareva Holding

AbbVie

Nipro Corp

Vetter

Sopharma

DPT Laboratories

Recipharm

NextPharma

Dishman

Aesica

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, and market share and growth rate of Contract Pharmaceutical Manufacturing in these regions, from 2011 to 2021 (forecast), like

North America

China

Europe

Japan

India

Southeast Asia

Split by product types, with sales, revenue, price, and market share and growth rate of each type, can be divided into

Active pharmaceutical ingredients (API)

Finished dosage formulations (FDF)

In a word, the report provides major statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Global Contract Pharmaceutical Manufacturing Consumption Market Report 2021

Table of Contents
1 Contract Pharmaceutical Manufacturing Overview 1
1.1 Product Overview and Scope of Contract Pharmaceutical Manufacturing 1
1.2 Classification of Contract Pharmaceutical Manufacturing 3
1.2.1 API 4
1.2.2 FDF 5
1.3 Applications of Contract Pharmaceutical Manufacturing 5
1.4 Contract Pharmaceutical Manufacturing Market by Regions 7
1.4.1 North America Status and Prospect (2011-2021) 7
1.4.2 China Status and Prospect (2011-2021) 8
1.4.3 Europe Status and Prospect (2011-2021) 9
1.4.4 Japan Status and Prospect (2011-2021) 10
1.4.5 India Status and Prospect (2011-2021) 10
1.4.6 Southeast Asia Status and Prospect (2011-2021) 11
1.5 Global Market Size of Contract Pharmaceutical Manufacturing (2011-2021) 11
1.5.1 Global Contract Pharmaceutical Manufacturing Revenue, Gross Margin and Gross (2011-2021) 11
1.5.2 Global Contract Pharmaceutical Manufacturing Gross and Growth Rate (2011-2021) 12
1.5.3 Global Contract Pharmaceutical Manufacturing Revenue and Growth Rate (2011-2021) 13
2 Global Contract Pharmaceutical Manufacturing Competition by Manufacturers, Type and Application 14
2.1 Global Contract Pharmaceutical Manufacturing Market Competition by Manufacturers 14
2.1.1 Global Contract Pharmaceutical Manufacturing Sales Revenue and Market Share of Key Manufacturers (2015 and 2016) 14
2.1.2 Global Contract Pharmaceutical Manufacturing Gross and Share by Manufacturers (2015 and 2016) 17
2.2 Global Contract Pharmaceutical Manufacturing by Type 20
2.3 Global Contract Pharmaceutical Manufacturing by Regions 23
2.3.1 Global Contract Pharmaceutical Manufacturing Sales and Market Share by Regions (2011-2021) 23
2.3.2 Global Contract Pharmaceutical Manufacturing Gross and Market Share by Regions (2011-2021) 25
2.4 Global Contract Pharmaceutical Manufacturing by Application 27
3 North America Contract Pharmaceutical Manufacturing 29
3.1 North America Contract Pharmaceutical Manufacturing Revenue and Gross (2011-2021) 29
3.1.1 North America Contract Pharmaceutical Manufacturing Sales Revenue and Growth Rate (2011-2021) 29
3.1.2 North America Contract Pharmaceutical Manufacturing Gross and Growth Rate (2011-2021) 30
3.1.3 North America Contract Pharmaceutical Manufacturing Gross Margin Trend (2011-2021) 30
3.2 North America Contract Pharmaceutical Manufacturing Sales Revenue and Market Share by Manufacturers 31
3.3 North America Contract Pharmaceutical Manufacturing Sales Revenue and Market Share by Type 32
3.4 North America Contract Pharmaceutical Manufacturing Sales Revenue and Market Share by Applications 33
4 China Contract Pharmaceutical Manufacturing 34
4.1 China Contract Pharmaceutical Manufacturing Revenue and Gross (2011-2021) 34
4.1.1 China Contract Pharmaceutical Manufacturing Sales Revenue and Growth Rate (2011-2021) 34
4.1.2 China Contract Pharmaceutical Manufacturing Gross and Growth Rate (2011-2021) 35
4.1.3 China Contract Pharmaceutical Manufacturing Gross Margin Trend (2011-2021) 35
4.2 China Contract Pharmaceutical Manufacturing Sales Revenue and Market Share by Manufacturers 36
4.3 China Contract Pharmaceutical Manufacturing Sales Revenue and Market Share by Type 37
4.4 China Contract Pharmaceutical Manufacturing Sales Revenue and Market Share by Applications 38
5 Europe Contract Pharmaceutical Manufacturing 39
5.1 Europe Contract Pharmaceutical Manufacturing Revenue and Gross (2011-2021) 39
5.1.1 Europe Contract Pharmaceutical Manufacturing Sales Revenue and Growth Rate (2011-2021) 39
5.1.2 Europe Contract Pharmaceutical Manufacturing Gross and Growth Rate (2011-2021) 40
5.1.3 Europe Contract Pharmaceutical Manufacturing Gross Margin Trend (2011-2021) 40
5.2 Europe Contract Pharmaceutical Manufacturing Sales Revenue and Market Share by Manufacturers 41
5.3 Europe Contract Pharmaceutical Manufacturing Sales Revenue and Market Share by Type 42
5.4 Europe Contract Pharmaceutical Manufacturing Sales Revenue and Market Share by Applications 43
6 Japan Contract Pharmaceutical Manufacturing 44
6.1 Japan Contract Pharmaceutical Manufacturing Revenue and Gross (2011-2021) 44
6.1.1 Japan Contract Pharmaceutical Manufacturing Sales Revenue and Growth Rate (2011-2021) 44
6.1.2 Japan Contract Pharmaceutical Manufacturing Gross and Growth Rate (2011-2021) 45
6.1.3 Japan Contract Pharmaceutical Manufacturing Gross Margin Trend (2011-2021) 45
6.2 Japan Contract Pharmaceutical Manufacturing Sales Revenue and Market Share by Manufacturers 46
6.3 Japan Contract Pharmaceutical Manufacturing Sales Revenue and Market Share by Type 47
6.4 Japan Contract Pharmaceutical Manufacturing Sales Revenue and Market Share by Applications 48
7 India Contract Pharmaceutical Manufacturing 49
7.1 India Contract Pharmaceutical Manufacturing Revenue and Gross (2011-2021) 49
7.1.1 India Contract Pharmaceutical Manufacturing Sales Revenue and Growth Rate (2011-2021) 49
7.1.2 India Contract Pharmaceutical Manufacturing Gross and Growth Rate (2011-2021) 50
7.1.3 India Contract Pharmaceutical Manufacturing Gross Margin Trend (2011-2021) 50
7.2 India Contract Pharmaceutical Manufacturing Sales Revenue and Market Share by Manufacturers 51
7.3 India Contract Pharmaceutical Manufacturing Sales Revenue and Market Share by Type 52
7.4 India Contract Pharmaceutical Manufacturing Sales Revenue and Market Share by Applications 53
8 Southeast Asia Contract Pharmaceutical Manufacturing 54
8.1 Southeast Asia Contract Pharmaceutical Manufacturing Revenue and Gross (2011-2021) 54
8.1.1 Southeast Asia Contract Pharmaceutical Manufacturing Sales Revenue and Growth Rate (2011-2021) 54
8.1.2 Southeast Asia Contract Pharmaceutical Manufacturing Gross and Growth Rate (2011-2021) 55
8.1.3 Southeast Asia Contract Pharmaceutical Manufacturing Gross Margin Trend (2011-2021) 55
8.2 Southeast Asia Contract Pharmaceutical Manufacturing Sales Revenue and Market Share by Manufacturers 56
8.3 Southeast Asia Contract Pharmaceutical Manufacturing Sales Revenue and Market Share by Type 57
8.4 Southeast Asia Contract Pharmaceutical Manufacturing Sales Revenue and Market Share by Applications 58
9 Analysis of Contract Pharmaceutical Manufacturing Industry Key Manufacturers 59
9.1 Catalent 59
9.1.1 Company Profile 59
9.1.2 Contract Pharmaceutical Manufacturing Revenue, Gross Margin and Gross 60
9.2 DPx 61
9.2.1 Company Profile 61
9.2.2 Contract Pharmaceutical Manufacturing Revenue, Gross Margin and Gross 62
9.3 Lonza 62
9.3.1 Company Profile 62
9.3.2 Contract Pharmaceutical Manufacturing Revenue, Gross Margin and Gross 63
9.4 Piramal Healthcare 64
9.4.1 Company Profile 64
9.4.2 Contract Pharmaceutical Manufacturing Revenue, Gross Margin and Gross 65
9.5 Aenova 66
9.5.1 Company Profile 66
9.5.2 Contract Pharmaceutical Manufacturing Revenue, Gross Margin and Gross 67
9.6 Jubilant 67
9.6.1 Company Profile 67
9.6.2 Contract Pharmaceutical Manufacturing Revenue, Gross Margin and Gross 68
9.7 Famar 69
9.7.1 Company Profile 69
9.7.2 Contract Pharmaceutical Manufacturing Revenue, Gross Margin and Gross 70
9.8 Boehringer Ingelheim 70
9.8.1 Company Profile 70
9.8.2 Contract Pharmaceutical Manufacturing Revenue, Gross Margin and Gross 71
9.9 Fareva Holding 71
9.9.1 Company Profile 71
9.9.2 Contract Pharmaceutical Manufacturing Revenue, Gross Margin and Gross 72
9.10 AbbVie 73
9.10.1 Company Profile 73
9.10.2 Contract Pharmaceutical Manufacturing Revenue, Gross Margin and Gross 74
9.11 Nipro Corp 74
9.11.1 Company Profile 74
9.11.2 Contract Pharmaceutical Manufacturing Revenue, Gross Margin and Gross 75
9.12 Vetter 75
9.12.1 Company Profile 75
9.12.2 Contract Pharmaceutical Manufacturing Revenue, Gross Margin and Gross 76
9.13 Sopharma 77
9.13.1 Company Profile 77
9.13.2 Contract Pharmaceutical Manufacturing Revenue, Gross Margin and Gross 78
9.14 DPT Laboratories 78
9.14.1 Company Profile 78
9.14.2 Contract Pharmaceutical Manufacturing Revenue, Gross Margin and Gross 79
9.15 Recipharm 80
9.15.1 Company Profile 80
9.15.2 Contract Pharmaceutical Manufacturing Revenue, Gross Margin and Gross 81
9.16 NextPharma 81
9.16.1 Company Profile 81
9.16.2 Contract Pharmaceutical Manufacturing Revenue, Gross Margin and Gross 82
9.17 Dishman 83
9.17.1 Company Profile 83
9.17.2 Contract Pharmaceutical Manufacturing Revenue, Gross Margin and Gross 84
9.18 Aesica 84
9.18.1 Company Profile 84
9.18.2 Contract Pharmaceutical Manufacturing Revenue, Gross Margin and Gross 86
10 Contract Pharmaceutical Manufacturing Technology and Development Trend 87
10.1 Contract Pharmaceutical Manufacturing Technology Analysis 87
10.1.1 Global Population Analysis 87
10.1.2 Industry Value Chain of Contract Pharmaceutical Manufacturing 89
10.2 Contract Pharmaceutical Manufacturing Technology Development Trend 89
10.2.1 Contract Pharmaceutical Manufacturing Bossiness Model 89
10.2.2 Pharmaceutical Quality Systems 91
10.2.3 Key Elements of Technology Transfer 92
11 Research Findings and Conclusion 93
Disclosure Section 94
Research Methodology 94
Data Source 95
China Disclaimer 95
List of Tables and Figures
Figure Picture of Contract Pharmaceutical Manufacturing 1
Figure Contract Pharmaceutical Manufacturing Industry Drivers 2
Figure Classification of Contract Pharmaceutical Manufacturing 3
Figure Global Revenue (M USD) Market Share of Contract Pharmaceutical Manufacturing by Types in 2015 4
Figure API Picture 4
Figure FDF Picture 5
Figure Applications of Contract Pharmaceutical Manufacturing 5
Figure Global Revenue (M USD) Market Share of Contract Pharmaceutical Manufacturing by Applications in 2015 6
Figure North America Contract Pharmaceutical Manufacturing Revenue (M USD) and Growth Rate (2011-2021) 7
Figure China Contract Pharmaceutical Manufacturing Revenue (M USD) and Growth Rate (2011-2021) 8
Figure Europe Contract Pharmaceutical Manufacturing Revenue (M USD) and Growth Rate (2011-2021) 9
Figure Japan Contract Pharmaceutical Manufacturing Revenue (M USD) and Growth Rate (2011-2021) 10
Figure India Contract Pharmaceutical Manufacturing Revenue (M USD) and Growth Rate (2011-2021) 10
Figure Southeast Asia Contract Pharmaceutical Manufacturing Revenue (M USD) and Growth Rate (2011-2021) 11
Table Global Contract Pharmaceutical Manufacturing Revenue, Gross Margin and Gross (2011-2021) 11
Figure Global Contract Pharmaceutical Manufacturing Gross and Growth Rate (2011-2021) 12
Figure Global Contract Pharmaceutical Manufacturing Revenue and Growth Rate (2011-2021) 13
Table Global Contract Pharmaceutical Manufacturing Sales Revenue (M USD) of Key Manufacturers (2015 and 2016) 14
Table Global Contract Pharmaceutical Manufacturing Sales Revenue Share by Manufacturers (2015 and 2016) 15
Figure 2015 Contract Pharmaceutical Manufacturing Sales Revenue Share by Manufacturers 16
Figure 2016 Contract Pharmaceutical Manufacturing Sales Revenue Share by Manufacturers 17
Table Global Contract Pharmaceutical Manufacturing Gross (M USD) by Manufacturers (2015 and 2016) 17
Table Global Contract Pharmaceutical Manufacturing Gross Share by Manufacturers (2015 and 2016) 18
Figure 2015 Global Contract Pharmaceutical Manufacturing Gross Share by Manufacturers 19
Figure 2016 Global Contract Pharmaceutical Manufacturing Gross Share by Manufacturers 20
Table Global Contract Pharmaceutical Manufacturing Sales Revenue (M USD) and Market Share by Type (2011-2021) 20
Table Global Contract Pharmaceutical Manufacturing Sales Revenue Share by Type (2011-2021) 21
Figure Sales Revenue Market Share of Contract Pharmaceutical Manufacturing by Type (2011-2021) 22
Figure Global Contract Pharmaceutical Manufacturing Sales Revenue Growth Rate by Type (2011-2021) 22
Table Global Contract Pharmaceutical Manufacturing Sales Revenue (M USD) and Market Share by Regions (2011-2021) 23
Table Global Contract Pharmaceutical Manufacturing Sales Revenue Share by Regions (2011-2021) 23
Figure Sales Revenue Market Share of Contract Pharmaceutical Manufacturing by Regions (2011-2021) 24
Figure Global Contract Pharmaceutical Manufacturing Sales Revenue Growth Rate by Regions (2011-2021) 24
Table Global Contract Pharmaceutical Manufacturing Gross and Market Share by Regions (2011-2021) 25
Table Global Contract Pharmaceutical Manufacturing Gross Share by Regions (2011-2021) 25
Figure Gross Market Share of Contract Pharmaceutical Manufacturing by Regions (2011-2021) 26
Figure Global Contract Pharmaceutical Manufacturing Gross Growth Rate by Regions (2011-2021) 26
Table Global Contract Pharmaceutical Manufacturing Sales Revenue (M USD) and Market Share by Application (2011-2021) 27
Table Global Contract Pharmaceutical Manufacturing Sales Revenue Share by Application (2011-2021) 27
Figure Sales Revenue Market Share of Contract Pharmaceutical Manufacturing by Application (2011-2021) 28
Figure Global Contract Pharmaceutical Manufacturing Sales Revenue Growth Rate by Applications (2011-2021) 28
Figure North America Contract Pharmaceutical Manufacturing Sales Revenue (M USD) and Growth Rate (2011-2021) 29
Figure North America Contract Pharmaceutical Manufacturing Gross (M USD) and Growth Rate (2011-2021) 30
Figure North America Contract Pharmaceutical Manufacturing Gross Margin Trend (2011-2021) 30
Table North America Contract Pharmaceutical Manufacturing Sales Revenue (M USD) by Manufacturers (2015 and 2016) 31
Table North America Contract Pharmaceutical Manufacturing Sales Revenue Market Share by Manufacturers (2015 and 2016) 31
Table North America Contract Pharmaceutical Manufacturing Sales Revenue (M USD) by Type (2015 and 2016) 32
Table North America Contract Pharmaceutical Manufacturing Sales Revenue Market Share by Type (2015 and 2016) 32
Table North America Contract Pharmaceutical Manufacturing Sales Revenue (M USD) by Applications (2015 and 2016) 33
Table North America Contract Pharmaceutical Manufacturing Sales Revenue Market Share by Applications (2015 and 2016) 33
Figure China Contract Pharmaceutical Manufacturing Sales Revenue (M USD) and Growth Rate (2011-2021) 34
Figure China Contract Pharmaceutical Manufacturing Gross (M USD) and Growth Rate (2011-2021) 35
Figure China Contract Pharmaceutical Manufacturing Gross Margin Trend (2011-2021) 35
Table China Contract Pharmaceutical Manufacturing Sales Revenue (M USD) by Manufacturers (2015 and 2016) 36
Table China Contract Pharmaceutical Manufacturing Sales Revenue Market Share by Manufacturers (2015 and 2016) 36
Table China Contract Pharmaceutical Manufacturing Sales Revenue (M USD) by Type (2015 and 2016) 37
Table China Contract Pharmaceutical Manufacturing Sales Revenue Market Share by Type (2015 and 2016) 37
Table China Contract Pharmaceutical Manufacturing Sales Revenue (M USD) by Applications (2015 and 2016) 38
Table China Contract Pharmaceutical Manufacturing Sales Revenue Market Share by Applications (2015 and 2016) 38
Figure Europe Contract Pharmaceutical Manufacturing Sales Revenue (M USD) and Growth Rate (2011-2021) 39
Figure Europe Contract Pharmaceutical Manufacturing Gross (M USD) and Growth Rate (2011-2021) 40
Figure Europe Contract Pharmaceutical Manufacturing Gross Margin Trend (2011-2021) 40
Table Europe Contract Pharmaceutical Manufacturing Sales Revenue (M USD) by Manufacturers (2015 and 2016) 41
Table Europe Contract Pharmaceutical Manufacturing Sales Revenue Market Share by Manufacturers (2015 and 2016) 41
Table Europe Contract Pharmaceutical Manufacturing Sales Revenue (M USD) by Type (2015 and 2016) 42
Table Europe Contract Pharmaceutical Manufacturing Sales Revenue Market Share by Type (2015 and 2016) 42
Table Europe Contract Pharmaceutical Manufacturing Sales Revenue (M USD) by Applications (2015 and 2016) 43
Table Europe Contract Pharmaceutical Manufacturing Sales Revenue Market Share by Applications (2015 and 2016) 43
Figure Japan Contract Pharmaceutical Manufacturing Sales Revenue (M USD) and Growth Rate (2011-2021) 44
Figure Japan Contract Pharmaceutical Manufacturing Gross (M USD) and Growth Rate (2011-2021) 45
Figure Japan Contract Pharmaceutical Manufacturing Gross Margin Trend (2011-2021) 45
Table Japan Contract Pharmaceutical Manufacturing Sales Revenue (M USD) by Manufacturers (2015 and 2016) 46
Table Japan Contract Pharmaceutical Manufacturing Sales Revenue Market Share by Manufacturers (2015 and 2016) 46
Table Japan Contract Pharmaceutical Manufacturing Sales Revenue (M USD) by Type (2015 and 2016) 47
Table Japan Contract Pharmaceutical Manufacturing Sales Revenue Market Share by Type (2015 and 2016) 47
Table Japan Contract Pharmaceutical Manufacturing Sales Revenue (M USD) by Applications (2015 and 2016) 48
Table Japan Contract Pharmaceutical Manufacturing Sales Revenue Market Share by Applications (2015 and 2016) 48
Figure India Contract Pharmaceutical Manufacturing Sales Revenue (M USD) and Growth Rate (2011-2021) 49
Figure India Contract Pharmaceutical Manufacturing Gross (M USD) and Growth Rate (2011-2021) 50
Figure India Contract Pharmaceutical Manufacturing Gross Margin Trend (2011-2021) 50
Table India Contract Pharmaceutical Manufacturing Sales Revenue (M USD) by Manufacturers (2015 and 2016) 51
Table India Contract Pharmaceutical Manufacturing Sales Revenue Market Share by Manufacturers (2015 and 2016) 51
Table India Contract Pharmaceutical Manufacturing Sales Revenue (M USD) by Type (2015 and 2016) 52
Table India Contract Pharmaceutical Manufacturing Sales Revenue Market Share by Type (2015 and 2016) 52
Table India Contract Pharmaceutical Manufacturing Sales Revenue (M USD) by Applications (2015 and 2016) 53
Table India Contract Pharmaceutical Manufacturing Sales Revenue Market Share by Applications (2015 and 2016) 53
Figure Southeast Asia Contract Pharmaceutical Manufacturing Sales Revenue (M USD) and Growth Rate (2011-2021) 54
Figure Southeast Asia Contract Pharmaceutical Manufacturing Gross (M USD) and Growth Rate (2011-2021) 55
Figure Southeast Asia Contract Pharmaceutical Manufacturing Gross Margin Trend (2011-2021) 55
Table Southeast Asia Contract Pharmaceutical Manufacturing Sales Revenue (M USD) by Manufacturers (2015 and 2016) 56
Table Southeast Asia Contract Pharmaceutical Manufacturing Sales Revenue Market Share by Manufacturers (2015 and 2016) 56
Table Southeast Asia Contract Pharmaceutical Manufacturing Sales Revenue (M USD) by Type (2015 and 2016) 57
Table Southeast Asia Contract Pharmaceutical Manufacturing Sales Revenue Market Share by Type (2015 and 2016) 57
Table Southeast Asia Contract Pharmaceutical Manufacturing Sales Revenue (M USD) by Applications (2015 and 2016) 58
Table Southeast Asia Contract Pharmaceutical Manufacturing Sales Revenue Market Share by Applications (2015 and 2016) 58
Table Catalent Company Profile 59
Table Contract Pharmaceutical Manufacturing Revenue (M USD), Gross Margin and Gross (M USD) of Catalent 2015-2016 60
Table DPx Company Profile 61
Table Contract Pharmaceutical Manufacturing Revenue (M USD), Gross Margin and Gross (M USD) of DPx 2015-2016 62
Table Lonza Company Profile 62
Table Contract Pharmaceutical Manufacturing Revenue (M USD), Gross Margin and Gross (M USD) of Lonza 2015-2016 63
Table Piramal Healthcare Company Profile 64
Table Contract Pharmaceutical Manufacturing Revenue (M USD), Gross Margin and Gross (M USD) of Piramal Healthcare 2015-2016 65
Table Aenova Company Profile 66
Table Contract Pharmaceutical Manufacturing Revenue (M USD), Gross Margin and Gross (M USD) of Aenova 2015-2016 67
Table Jubilant Company Profile 67
Table Contract Pharmaceutical Manufacturing Revenue (M USD), Gross Margin and Gross (M USD) of Jubilant 2015-2016 68
Table Famar Company Profile 69
Table Contract Pharmaceutical Manufacturing Revenue (M USD), Gross Margin and Gross (M USD) of Famar 2015-2016 70
Table Boehringer Ingelheim Company Profile 70
Table Contract Pharmaceutical Manufacturing Revenue (M USD), Gross Margin and Gross (M USD) of Boehringer Ingelheim 2015-2016 71
Table Fareva Holding Company Profile 71
Table Contract Pharmaceutical Manufacturing Revenue (M USD), Gross Margin and Gross (M USD) of Fareva Holding 2015-2016 72
Table AbbVie Company Profile 73
Table Contract Pharmaceutical Manufacturing Revenue (M USD), Gross Margin and Gross (M USD) of AbbVie 2015-2016 74
Table Nipro Corp Company Profile 74
Table Contract Pharmaceutical Manufacturing Revenue (M USD), Gross Margin and Gross (M USD) of Nipro Corp 2015-2016 75
Table Vetter Company Profile 75
Table Contract Pharmaceutical Manufacturing Revenue (M USD), Gross Margin and Gross (M USD) of Vetter 2015-2016 76
Table Sopharma Company Profile 77
Table Contract Pharmaceutical Manufacturing Revenue (M USD), Gross Margin and Gross (M USD) of Sopharma 2015-2016 78
Table DPT Laboratories Company Profile 78
Table Contract Pharmaceutical Manufacturing Revenue (M USD), Gross Margin and Gross (M USD) of DPT Laboratories 2015-2016 79
Table Recipharm Company Profile 80
Table Contract Pharmaceutical Manufacturing Revenue (M USD), Gross Margin and Gross (M USD) of Recipharm 2015-2016 81
Table NextPharma Company Profile 81
Table Contract Pharmaceutical Manufacturing Revenue (M USD), Gross Margin and Gross (M USD) of NextPharma 2015-2016 82
Table Dishman Company Profile 83
Table Contract Pharmaceutical Manufacturing Revenue (M USD), Gross Margin and Gross (M USD) of Dishman 2015-2016 84
Table Aesica Company Profile 84
Table Contract Pharmaceutical Manufacturing Revenue (M USD), Gross Margin and Gross (M USD) of Aesica 2015-2016 86
Figure Demographics Drive Access Concerns 87
Figure Global Population Age Analysis 88
Figure Outsourcing across the Industry Value Chain of Contract Pharmaceutical Manufacturing 89
Figure Contract Pharmaceutical Manufacturing Existing Bossiness Model 90
Figure Contract Pharmaceutical Manufacturing Emerging Bossiness Model 90
Figure Emerging Opportunity Areas of Contract Pharmaceutical Manufacturing 91
Figure Pharmaceutical Quality System 92
  • High Potency APIs /HPAPI Market by Type (Innovative, Generic), Synthesis (Synthetic, Biotech, moAB, Vaccines, Recombinant Proteins), Manufacturer (Captive and Merchant), Therapy (Oncology, Glaucoma, Hormonal Imbalance) - Global Forecasts to 2023
    Published: 19-Apr-2018        Price: US 5650 Onwards        Pages: 216
    “The global HPAPIsmarket projected to grow at a CAGR of 8.7%”The global HPAPIs market is expected to reach USD 26.84 billion by 2023 from USD 17.72 billion in 2018, at a CAGR 8.7%. The growth in this market is driven by factors such as increasing demand for oncology drugs, growing demand for antibody-drug conjugates, increasing focus of leading pharmaceutical companies on HPAPIs, advancements in HPAPI manufacturing technologies, and growing focus on precision medicine.On the......
  • Global Chikungunya Fever Drugs Market Research Report 2018
    Published: 19-Apr-2018        Price: US 2900 Onwards        Pages: 112
    This report studies the global Chikungunya Fever Drugs market status and forecast, categorizes the global Chikungunya Fever Drugs market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa. In 2017, the global Chikungunya Fever Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx.x %......
  • Global Ureter Cancer Drugs Market Research Report 2018
    Published: 19-Apr-2018        Price: US 2900 Onwards        Pages: 107
    This report studies the global Ureter Cancer Drugs market status and forecast, categorizes the global Ureter Cancer Drugs market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa. In 2017, the global Ureter Cancer Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx.x % between 201......
  • Global Beta Catenin Market Research Report 2018
    Published: 19-Apr-2018        Price: US 2900 Onwards        Pages: 102
    This report studies the global Beta Catenin market status and forecast, categorizes the global Beta Catenin market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa. In 2017, the global Beta Catenin market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx.x % between 2018 and 2025. ......
  • Germany Interferon Alpha-2a Biosimilar Market Research Report 2018
    Published: 19-Apr-2018        Price: US 3400 Onwards        Pages: 99
    The global Interferon Alpha-2a Biosimilar market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Germany plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%. This report studies the Interferon Alpha-2a Biosimilar development status and future trend in Germany, focuses on top players in......
  • Global Guillain-Barre Syndrome Drugs Market Research Report 2018
    Published: 19-Apr-2018        Price: US 2900 Onwards        Pages: 102
    This report studies the global Guillain-Barre Syndrome Drugs market status and forecast, categorizes the global Guillain-Barre Syndrome Drugs market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa. In 2017, the global Guillain-Barre Syndrome Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, wit......
  • Global Resistant Pseudomonas Aeruginosa Infections Drugs Market Research Report 2018
    Published: 19-Apr-2018        Price: US 2900 Onwards        Pages: 101
    This report studies the global Resistant Pseudomonas Aeruginosa Infections Drugs market status and forecast, categorizes the global Resistant Pseudomonas Aeruginosa Infections Drugs market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa. In 2017, the global Resistant Pseudomonas Aeruginosa Infections Drugs market size was xx million US$ and it......
  • Global Ambient Lighting Software Market Research Report 2018
    Published: 19-Apr-2018        Price: US 2900 Onwards        Pages: 103
    This report studies the global Ambient Lighting Software market status and forecast, categorizes the global Ambient Lighting Software market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa. In 2017, the global Ambient Lighting Software market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of ......
  • Global Rapamune (Sirolimus) Sales Market Report 2018
    Published: 19-Apr-2018        Price: US 4000 Onwards        Pages: 109
    This report studies the global Rapamune (Sirolimus) market status and forecast, categorizes the global Rapamune (Sirolimus) market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). In 2017, the global Rapamune (Sirolimus) market size was xx million US$ and it is expected to reach xx million US$ by ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs